1. Prognostic significance of p16 in squamous cell carcinoma of the larynx and hypopharynx
    Jessica Meshman et al, 2017, American Journal of Otolaryngology CrossRef
  2. Integrative Genomics and Transcriptomics Analysis Reveals Potential Mechanisms for Favorable Prognosis of Patients with HPV-Positive Head and Neck Carcinomas
    Wensheng Zhang et al, 2016, Sci Rep CrossRef
  3. Influence of human papillomavirus and p16INK4a on treatment outcome of patients with anal cancer
    Stefan Alexander Koerber et al, 2014, Radiotherapy and Oncology CrossRef
  4. Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
    E. E. W. Cohen et al, 2017 CrossRef
  5. p16INK4a overexpression is associated with CDKN2A mutation and worse prognosis in HPV-negative laryngeal squamous cell carcinomas
    Ana B. Larque et al, 2015, Virchows Arch CrossRef
  6. Branchiogenic carcinoma with high-risk-type human papillomavirus infection: A case report
    Hiroyuki Maeda et al, 2016 CrossRef
  7. Initial evidence for Sec62 as a prognostic marker in advanced head and neck squamous cell carcinoma
    SILKE WEMMERT et al, 2016 CrossRef
  8. P16 Cutoff in Head and Neck Squamous Cell Carcinoma: Correlation between Tumor and Patient Characteristics and Outcome
    Marco Carlo Merlano et al, 2016, The International Journal of Biological Markers CrossRef
  9. Epigenetic down-regulation of SOX2 is an independent poor prognostic factor for hypopharyngeal cancers
    Mehmet Ozgur Avincsal et al, 2018, Histopathology CrossRef
  10. Viral Oncology: Molecular Biology and Pathogenesis
    Uyen Ngoc Mui et al, 2017, JCM CrossRef
  11. Decreasing cytokeratin 17 expression in head and neck cancer predicts nodal metastasis and poor prognosis: The first evidence
    E.-S. Xu et al, 2018, Clin Otolaryngol CrossRef
  12. Invasives Karzinom der Vulva
    Sven Ackermann et al, 2018 CrossRef
  13. ECE-1 overexpression in head and neck cancer is associated with poor tumor differentiation and patient outcome
    Enny-Sonia Xu et al, 2018, Oral Dis CrossRef
  14. Human Papillomavirus in Head and Neck Squamous Cell Carcinomas in a South African Cohort
    Tumelo R. Sekee et al, 2018, Papillomavirus Research CrossRef
  15. Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infection
    Yukashi Yamashita et al, 2018, Eur Arch Otorhinolaryngol CrossRef
  16. p16 Influence on Laryngeal Squamous Cell Carcinoma Relapse and Survival
    Alvaro Sánchez Barrueco et al, 2019, Otolaryngol Head Neck Surg CrossRef
  17. High-risk type human papillomavirus infection and p16 expression in laryngeal cancer
    Asanori Kiyuna et al, 2019, Infect Agents Cancer CrossRef
  18. Oral squamous cell carcinoma and hyperkeratotic lesions with BRAF inhibitors
    E. Vigarios et al, 2015, Br J Dermatol CrossRef
  19. Clinical, morphological, and prognostic features of head and neck squamous cell carcinoma associated with human papillomavirus
    A. I. Stukan et al, 2019, Onkol. Z. im. P.A. Gercena CrossRef
  20. Low prevalence of HPV‐induced oral squamous cell carcinoma in Geneva, Switzerland
    Ana C. Vidal Loustau et al, 2019, Oral Dis CrossRef
  21. Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review
    Volker Budach et al, 2019, The Lancet Oncology CrossRef
  22. Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
    Barbara Burtness et al, 2019, JAMA Oncol CrossRef
  23. Association of the expression of p53 and p16INK4A with the clinical and morphological characteristicsof patients with head and neck squamous cell cancer
    A. I. Stukan et al, 2019, Arkh. patol. CrossRef
  24. Predictive role of toll-like receptors 2, 4, and 9 in oral tongue squamous cell carcinoma
    Laura K. Mäkinen et al, 2015, Oral Oncology CrossRef
  25. High-grade acute organ toxicity and p16INK4A expression as positive prognostic factors in primary radio(chemo)therapy for patients with head and neck squamous cell carcinoma
    Narges Tehrany et al, 2015, Strahlenther Onkol CrossRef
  26. Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial
    Robert Haddad et al, 2019, Oral Oncology CrossRef
  27. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial
    Jean-Pascal H Machiels et al, 2015, The Lancet Oncology CrossRef
  28. The role of HPV RNA transcription, immune response-related gene expression and disruptiveTP53mutations in diagnostic and prognostic profiling of head and neck cancer
    Gunnar Wichmann et al, 2015, Int. J. Cancer CrossRef
  29. Meta-analysis of survival in patients with HNSCC discriminates risk depending on combined HPV and p16 status
    Annekatrin Coordes et al, 2016, Eur Arch Otorhinolaryngol CrossRef
  30. Human papillomavirus DNA in pharyngeal scrapes as a marker of HPV-related squamous cell cancer of the oropharynx
    Miroslaw Snietura et al, 2015, Journal of Clinical Virology CrossRef
  31. Human papillomavirus infection and immunohistochemical expression of cell cycle proteins pRb, p53, and p16INK4a in sinonasal diseases
    Yukashi Yamashita et al, 2015, Infect Agents Cancer CrossRef
  32. Epstein-Barr virus infection is strictly associated with the metastatic spread of sinonasal squamous-cell carcinomas
    Johannes Doescher et al, 2015, Oral Oncology CrossRef
  33. Detection of human papillomavirus in laryngeal squamous cell carcinoma: Systematic review and meta-analysis
    Ricardo Ribeiro Gama et al, 2016, The Laryngoscope CrossRef
  34. Immune cells and prognosis in HPV-associated oropharyngeal squamous cell carcinomas: Review of the literature
    Camelia Nami Saber et al, 2016, Oral Oncology CrossRef
  35. Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies
    Philippe E. Spiess et al, 2016, CA: A Cancer Journal for Clinicians CrossRef
  36. Diagnostic accuracy of p16INK4a immunohistochemistry in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
    Elena-Sophie Prigge et al, 2017, Int J Cancer CrossRef
  37. HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma
    Jian Wang et al, 2019, Sci Rep CrossRef
  38. HPV DNA in saliva from patients with SCC of the head and neck is specific for p16-positive oropharyngeal tumours
    Jason K. Wasserman et al, 2017, J of Otolaryngol - Head & Neck Surg CrossRef
  39. A model using concomitant markers for predicting outcome in human papillomavirus positive oropharyngeal cancer
    Cinzia Bersani et al, 2017, Oral Oncology CrossRef
  40. Effect of high-risk human papillomavirus in esophageal squamous cell carcinoma in Somalian and Turkish cases
    Yılmaz Baş et al, 2019 CrossRef
  41. Afatinib versus methotrexate as second-line treatment in Asian patients with recurrent or metastatic squamous cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 3): an open-label, randomised phase III trial
    Y Guo et al, 2019 CrossRef
  42. Serum profiling identifies ibrutinib as a treatment option for young adults with B-cell acute lymphoblastic leukaemia.
    Stephanie Jordaens et al, 2020, Br J Haematol CrossRef
  43. Are Histomorphological Features Predictive of p16 Immunopositivity Different for Oral and Oropharyngeal Squamous Cell Carcinoma?
    Aishwary Gayatree et al, 2020, Indian J Surg Oncol CrossRef
  44. The prognostic value of HPV combined p16 status in patients with anal squamous cell carcinoma: a meta-analysis
    Guorui Sun et al, 2018, Oncotarget CrossRef
  45. Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia
    Laurie Freire Boullosa et al, 2018, Oncotarget CrossRef
  46. Methylation of CpG sites in the upstream regulatory region, physical status and mRNA expression of HPV-6 in adult-onset laryngeal papilloma
    Zeyi Deng et al, 2017, Oncotarget CrossRef
  47. Detection of HPV infection in head and neck cancers: Promise and pitfalls in the last ten years: A meta-analysis
    Carolin G�tz et al, 2018, mol clin onc CrossRef
  48. Detection of human papillomavirus in branchial cleft cysts
    Taro Ikegami et al, 2018, Oncol Lett CrossRef
  49. Basaloid squamous cell carcinoma with adenoid cystic‐like features of the head and neck region: A report of two cases
    Kimihide Kusafuka et al, 2020, Pathology International CrossRef
  50. PRINS lncRNA Is a New Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas
    Magda Kopczyńska et al, 2020, Diagnostics CrossRef
  51. Oropharyngeal carcinoma: a single institution study of 338 primaries with special reference to high-risk human papillomavirus-mediated carcinoma with aggressive behavior
    Borislav A. Alexiev et al, 2020, Pathology - Research and Practice CrossRef
  52. Viral markers in nasopharyngeal carcinoma: A systematic review and meta-analysis on the detection of p16INK4a, human papillomavirus (HPV), and Ebstein-Barr virus (EBV)
    Tristan Tham et al, 2020, American Journal of Otolaryngology CrossRef
  53. Feasibility of Immunohistochemical p16 Staining in the Diagnosis of Human Papillomavirus Infection in Patients With Squamous Cell Carcinoma of the Head and Neck: A Systematic Review and Meta-Analysis
    Huanhuan Wang et al, 2020, Front. Oncol. CrossRef
  54. Prediction of Response in Head and Neck Tumor: Focus on Main Hot Topics in Research
    Liliana Belgioia et al, 2021, Front. Oncol. CrossRef
  55. Inhomogeneity of stiffness and density of the extracellular matrix within the leukoplakia of human oral mucosa as potential physicochemical factors leading to carcinogenesis
    Katarzyna Pogoda et al, 2021, Translational Oncology CrossRef
  56. Prognostic significance of hypoxia-inducible factor-1α expression in advanced pharyngeal cancer without human papillomavirus infection
    S Agena et al, 2021, J. Laryngol. Otol. CrossRef
  57. Sensitivity and Specificity of Human Papillomavirus (HPV) 16 Early Antigen Serology for HPV-Driven Oropharyngeal Cancer: A Systematic Literature Review and Meta-Analysis
    Julia Hibbert et al, 2021, Cancers CrossRef
  58. Can dual staining with p16 and Ki67 be biomarkers of epithelial dysplasia in oral lesions?
    Anju Bharti et al, 2021, J Can Res Ther CrossRef
  59. Alcohol and Head and Neck Cancer: Updates on the Role of Oxidative Stress, Genetic, Epigenetics, Oral Microbiota, Antioxidants, and Alkylating Agents.
    Marco Fiore, 0 CrossRef
  60. Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma
    Roberto Gallus et al, 2022, Vaccines CrossRef
  61. Impact of p16 Alterations and Pretreatment Anemia on Toxicity in Head and Neck Cancer Patients Undergoing Definitive Radiochemotherapy
    Martina Becker-Schiebe et al, 2015, Oncol Res Treat CrossRef
  62. HPV and head and neck cancers: Towards early diagnosis and prevention
    Luisa Galati et al, 2022, Tumour Virus Research CrossRef
  63. Human papillomavirus‐driven head and neck cancers in Japan during 2008–2009 and 2018–2019: The BROADEN study
    Ken‐ichi Nibu et al, 2024, Cancer Science CrossRef
  64. The Role of Biomarkers in HPV-Positive Head and Neck Squamous Cell Carcinoma: Towards Precision Medicine
    Antea Krsek et al, 2024, Diagnostics CrossRef
  65. Histomorphology based prediction of p16 immunopositivity and p16/HPV DNA co-positivity in oral squamous cell carcinoma
    Farhat Naz et al, 2024, Annals of Diagnostic Pathology CrossRef
  66. Survival Outcome in True Carcinoma of Unknown Primary (tCUP) with p16 + Cervical Metastasis
    Muhammad Faisal et al, 2023, Int Arch Otorhinolaryngol CrossRef
  67. Evolution of testing for the diagnosis of human papillomavirus (HPV) status in head and neck squamous cell carcinoma: Where from and where to?
    Aabida Khan et al, 2025, Oral Oncology CrossRef